MUC4 is a new diagnostic marker for diffuse alveolar damage

MUC4 is a new diagnostic marker for diffuse alveolar damage - Diagnostic Vlaue of MUC4

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023611

Enrollment

125

Registered

2016-10-01

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Alveolar Damage

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with difuse alveolar damage, suchas acute respiratory distress syndrome, lung drug injury, and acute excervation of interstitial pneumonia. As a control group, patients with other pulmonary disease such as, bacterial pneumonia and srcoidosis, and healthy adults.

Exclusion criteria

Exclusion criteria: People who we can not get their consent on paper.

Design outcomes

Primary

Measure	Time frame
A correlation between serum MUC4 and severity of neutrophic inflammation of the lungs in patients with diffuse alevolar damage	—

Countries

Japan

Contacts

Public ContactHiromitsu Ohta

Saitama Medical Center Jichi Medical University Department of Respiratory Medicine

hoota@jichi.ac.jp048-647-2111

Outcome results